Literature DB >> 16442325

[Comparison of two routine screening strategies for gestational diabetes mellitus: the experience of Jean-Verdier Hospital].

M Benchimol1, E Cosson, C Faure, L Carbillon, R Attali, M Uzan.   

Abstract

OBJECTIVE: Screening strategies for gestational diabetes mellitus are controversial. Thus, we sought to determine the benefits of universal screening. PATIENTS AND METHODS: Prospective study with 2121 women involved but 1610 really screened (75.9%). According to WHO's recommendations, the strategy implemented was one-step, universal screening with a 75g oral glucose tolerance test. Screening was performed between 24 and 28 weeks of gestation or earlier if risk factors were identified. Results were compared to previous year (2001) then only a selective screening was done.
RESULTS: Application of universal screening increased the prevalence of gestational diabetes mellitus (8.39% to 15.65%). Out of the 252 patients with gestational diabetes, 66 did not display any identified risk factor (26.19%). Some new risk factors have been identified: age>30, Asian, Indian or Pakistan ethnies. If these new risk factors were applied, this super selective screening would have a sensibility of 96%. DISCUSSION AND
CONCLUSION: Universal screening seems to be the most appropriate routine screening strategy because it is difficult to know exactly the specific risk factors of a population to do a super selective screening.

Entities:  

Mesh:

Year:  2006        PMID: 16442325     DOI: 10.1016/j.gyobfe.2005.11.010

Source DB:  PubMed          Journal:  Gynecol Obstet Fertil        ISSN: 1297-9589


  2 in total

1.  Prevalence of gestational diabetes and associated risk factors in the population of Safi Province in Morocco.

Authors:  Hamid Chamlal; Mohamed Mziwira; Mohammed El Ayachi; Rekia Belahsen
Journal:  Pan Afr Med J       Date:  2020-11-26

2.  Diagnostic and prognostic performances over 9 years of a selective screening strategy for gestational diabetes mellitus in a cohort of 18,775 subjects.

Authors:  Emmanuel Cosson; Amélie Benbara; Isabelle Pharisien; Minh Tuan Nguyen; Aurélie Revaux; Boris Lormeau; Dorian Sandre-Banon; Nabil Assad; Camille Pillegand; Paul Valensi; Lionel Carbillon
Journal:  Diabetes Care       Date:  2012-11-12       Impact factor: 19.112

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.